Results 141 to 150 of about 7,732 (197)

Clinical significance of CD155 expression and correlation with immune cell infiltration in triple-negative breast cancer. [PDF]

Transl Cancer Res
Zhao Y, Wang J, Sun T, Jiang S, Xie Z, Lai J, Sang G, Jin X.   +7 more
europepmc   +1 more source

Post-radiation targeting of TIGIT and CD96 improved immunotherapy efficacy in head and neck squamous cell carcinoma. [PDF]

Mol Med
Salah M, Saito M, Kawaguchi H, Shimizu Y, Fujita Y, Mukumoto N, Kotani J, Shinomiya H, Ishihara T, Miyawaki D, Nibu NI, Sasaki R.   +11 more
europepmc   +1 more source

CD155-TIGIT/CD96/CD226 immune checkpoint axis interacting with tumor-infiltrating lymphocytes to exhibit diverse prognostic effects on breast cancer: a cohort study. [PDF]

Front Immunol
Ou X, Yin J, Shi F, Zhao Y, Zhou Q, Yuan K, Lyu S, Wu J, Li Y, Song Q.   +9 more
europepmc   +1 more source

An evolutionary T119R substitution in the macaque T-cell immunoreceptor TIGIT enables proteolytic shedding and reveals clinical antibody vulnerabilities. [PDF]

J Biol Chem
Pirillo E, Freenor V F, Wamba BEN, Bhatnagar S, Mondal T, Tushir-Singh J.   +5 more
europepmc   +1 more source

Perturbed CD8⁺ T cell TIGIT/CD226/PVR axis despite early initiation of antiretroviral treatment in HIV infected individuals [PDF]

, 2017
Betts, Michael R., Buggert, Marcus, Deeks, Steven G., Frederiksen, Juliet, Hecht, Frederick Mm, Karlsson, Annika C., Ljunggren, Hans-Gustaf, Lund, Ole, Naji, Ali, Reyes-Terán, Gustavo, Scharf, Lydia, Sönnerborg, Anders, Tauriainen, Johanna   +12 more
core   +1 more source

Targeting T cell exhaustion in colorectal cancer: emerging roles of LAG-3, TIM-3, and TIGIT signaling in overcoming immunotherapy resistance. [PDF]

Cell Commun Signal
Zamani P, Barootchi E, Firouzabadi A, Tonekaboni MS, Saleki K, Yazdanpanah N, Rezaei N.   +6 more
europepmc   +1 more source

Natural killer cell exhaustion in ovarian cancer: from molecular suppression to therapeutic revival. [PDF]

Front Immunol
Ning J, Yao L.
europepmc   +1 more source

Anti-tumor effect of intratumoral administration of induced pluripotent stem cell-derived NKT cells on glioblastoma through CD155/DNAM-1 interaction. [PDF]

Stem Cells Transl Med
Ozaki K, Aoki T, Kobayashi M, Takami M, Kobayashi M, Ito T, Ogawa K, Tanaka H, Nishii K, Nishimura K, Motoyoshi K, Kojima I, Katsumi D, Shimizu D, Wang H, Kimura MY, Hirahara K, Koseki H, Higuchi Y, Motohashi S.   +19 more
europepmc   +1 more source

Multidimensional plasticity of natural killer cells in tumours. [PDF]

Cell Death Dis
Yang X, Song Z, Chen L, Jia Q, Li M.
europepmc   +1 more source

Učinek protitelesa proti CD155 na invazijo celic glioblastoma

Glioblastoma is a primary brain tumor that is one of the most aggressive and deadliest malignant diseases. Despite treatment, which includes maximum possible surgical removal and subsequent radiotherapy and chemotherapy with temozolomide, it remains incurable. The rapid invasion of glioblastoma cells into the surrounding brain prevents complete removal
openaire   +1 more source